← All companies

ASPI · CIK 0001921865

What ASP Isotopes Inc. told the SEC could break it.

ASP Isotopes' disclosures cluster around concentration on every axis. Its revenue leans on a handful of customers — two in its construction-services segment were 32.2% ($7.7M) and 13.7% ($3.3M) of 2025 consolidated revenue — and it expects its future enriched-isotope business to depend on a limited number of buyers, notably TerraPower. Its core operations are geographically concentrated in South Africa, where the enrichment plants, Renergen gas project, and PET Labs sit, adding local political, economic, and currency risk. Underpinning it all is a sensitive, highly regulated nuclear-enrichment business facing export controls and licensing hurdles while depending on a limited set of suppliers for centrifuge components and fragile feedstock — Russia has historically been the sole global source of carbon-14.

4 self-disclosed vulnerabilities, pulled from its own filings — each in the company’s words, with the source. This is the risk register almost nobody reads.

In its own words

What could break it.

Customer concentration

  • construction segment two customers = 32.2% ($7.7M) and 13.7% ($3.3M) of 2025 consolidated revenue; future QLE isotope revenue heavily dependent on TerraPower/few customershigh

    ASP Isotopes has heavy customer concentration — two customers in its construction-services (Skyline) segment were 32.2% ($7.7M) and 13.7% ($3.3M) of consolidated revenue in 2025, and one isotope customer was 14% in 2024 — and it expects its QLE enriched-isotope business to depend on a limited number of customers (notably TerraPower) under long-term contracts; loss of a key customer would materially hurt revenue. (Construction customers not named, so the broader concentration is recorded here.)

    There were two customers in the construction services segment representing $ 7.7 million and $ 3.3 million, or 32.2 % and 13.7 %, respectively, o f the Company's consolidated revenues for the year ended December 31, 2025 .

    SEC filing →As of 2026

Geographic concentration

  • core operations concentrated in South Africa (enrichment plants, Renergen Virginia Gas, PET Labs) amid poor socio-economic conditionsmedium

    ASP Isotopes' enrichment plants are being constructed in South Africa, and its Renergen Virginia Gas Project and PET Labs radiopharmaceutical operations are also in South Africa (Free State Province), a region with poor socio-economic conditions (31.9% unemployment) that raise community/employment expectations and operational risk; this geographic concentration exposes the company to South African political, economic and currency risk (its Skyline construction arm operates in Hong Kong).

    Renergen's Virginia Gas Plant is located in the Free State Province of South Africa. South Africa's unemployment rate was 31.9% in the third quarter of 2024. Poor socio-economic conditions in these communities increase expectations for employment from businesses operating in these communities

    SEC filing →As of 2026

Regulatory & policy

  • nuclear enrichment export controls / weapons-proliferation limits, facility permits/licenses, FDA/EMA radioisotope regulation, and evolving tariffs/IEEPAmedium

    Uranium/lithium enrichment is among the most sensitive nuclear technologies — highly controlled, subject to export limits and public-disclosure restrictions — and ASPI's facilities require extensive regulatory approvals, permits and licenses; its radioisotopes may also be regulated by the FDA/Health Canada/EMA, and it faces evolving U.S. tariffs/IEEPA actions (a February 2026 Supreme Court ruling struck down certain IEEPA tariffs), creating multi-front regulatory risk.

    Enrichment is among the most sensitive nuclear technologies because it can produce weapons-grade materials, and our technology is highly controlled and subject to limitations on public disclosure or export.

Supplier concentration

  • limited third-party suppliers for centrifuge/enrichment-plant components; Russia historically the sole global supplier of C-14medium

    ASP Isotopes depends on a limited number of third-party suppliers for components needed to construct the centrifuges and equipment for its South African enrichment plants, and the isotope supply chain is fragile — Russia has historically been the sole supplier of carbon-14 (used as a pharmaceutical/agrochemical tracer) with inconsistent service — so a material interruption in components or feedstock could prevent or delay its development programs.

    We depend upon a limited number of third-party suppliers for certain components required to construct the centrifuges and other equipment for the enrichment plants that are being constructed in South Africa.

    SEC filing →As of 2026

The hidden graph

Who it depends on, and who depends on it.

Relationships surfaced from filings — including ones disclosed by the other side, which is how the non-obvious ones come to light.

Its customers

  • TerraPower LLC

    Agreements with TerraPower LLC On April 4, 2024, we entered into an agreement with TerraPower to develop a conceptual design, refined cost/schedule/financing, risk register, and term sheet for a HALEU facility (the “TerraPower Agreement”).

    Cited →

In the MyPRIA app, this is checked against the companies you actually own.

← World Watch